American Journal of Epidemiology Vol. 134, No. 10: 1206-1211
Copyright © 1991 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
Antibody to Hepatitis C Virus among Cardiac Surgery Patients, Homosexual Men, and Intravenous Drug Users in Baltimore, Maryland
From the Department of Epidemiology, Infectious Diseases Program, The Johns Hopkins University School of Hygiene and Public Health Baltimore, MD
Reprint requests to Dr. Kenrad E Nelson, Room 763, 624 N Broadway, Baltimore, MD 21205
In order to define the risk factors for infection with hepatitis C virus, the authors determined the prevalence and incidence of antibodies to hepatitis C in three cohorts in Baltimore, Maryland, enrolled in prospective studies of human immunodeficiency virus (HIV-1) infection. Among 500 multitransfused patients who underwent cardiac surgery in 1985 and 1986,12 (2.4%) were hepatitis C seropositive before surgery while 19 (3.9%) developed antibodies in the 812 months after surgery. The seroprevalence of hepatitis C virus among 225 intravenous drug users followed since 1988 was 85%, which did not vary by HIV1 status. Longer duration of intravenous drug use was significantly associated with hepatitis C seropositivity. Among 926 homosexual/bisexual men followed since 1984, 15 (1.6%) were hepatitis C seropositive; only intravenous drug use and a history of hepatitis A were marginally associated with hepatitis C in this population. No association was found between hepatitis C virus and HIV1 or sexual behavior variables in this population. These data suggest that hepatitis C is readily transmitted by blood exposure, but is transmitted inefficiently by sexual means. Am J Epidemiol 1991 ;134:120611.
blood transfusion; hepatits; HIV-1; sex hebaviour; substance abuse
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. A. Jaffe and P. L. Kimmel Chronic Nephropathies of Cocaine and Heroin Abuse: A Critical Review Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 655 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Nguyen, S. K. Herrine, C. A. Laine, K. Ruth, and D. S. Weinberg Description of a New Hepatitis C Risk Assessment Tool Arch Intern Med, September 26, 2005; 165(17): 2013 - 2018. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Krahn, J. B. Wong, J. Heathcote, L. Scully, and L. Seeff Estimating the Prognosis of Hepatitis C Patients Infected by Transfusion in Canada between 1986 and 1990 Med Decis Making, January 1, 2004; 24(1): 20 - 29. [Abstract] [PDF] |
||||
![]() |
M A Balogun, M E Ramsay, J V Parry, L Donovan, N J Andrews, J A Newham, C McGarrigle, K A Harris, and C G Teo A national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection Sex Transm Inf, August 1, 2003; 79(4): 301 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Sulkowski and D. L. Thomas Hepatitis C in the HIV-Infected Person Ann Intern Med, February 4, 2003; 138(3): 197 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Herrine Approach to the Patient with Chronic Hepatitis C Virus Infection Ann Intern Med, May 21, 2002; 136(10): 747 - 757. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E Thorpe, L. J Ouellet, R. Hershow, S. L Bailey, I. T Williams, J. Williamson, E. R Monterroso, and R. S Garfein Risk of Hepatitis C Virus Infection among Young Adult Injection Drug Users Who Share Injection Equipment Am. J. Epidemiol., April 1, 2002; 155(7): 645 - 653. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Patrick, M. W. Tyndall, P. G.A. Cornelisse, K. Li, C. H. Sherlock, M. L. Rekart, S. A. Strathdee, S. L. Currie, {d.{d. Schechter, and M. V. O'Shaughnessy Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection Can. Med. Assoc. J., October 1, 2001; 165(7): 889 - 895. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. van Beek, R. Dwyer, G. J Dore, K. Luo, and J. M Kaldor Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study BMJ, August 15, 1998; 317(7156): 433 - 437. [Abstract] [Full Text] |
||||
![]() |
P. G. O'Connor, P. A. Selwyn, and R. S. Schottenfeld Medical Care for Injection-Drug Users with Human Immunodeficiency Virus Infection N. Engl. J. Med., August 18, 1994; 331(7): 450 - 459. [Full Text] |
||||
![]() |
D. L. Thomas, S. H. Factor, G. D. Kelen, A. S. Washington, E. Taylor Jr, and T. C. Quinn Viral Hepatitis in Health Care Personnel at The Johns Hopkins Hospital: The Seroprevalence of and Risk Factors for Hepatitis B Virus and Hepatitis C Virus Infection Arch Intern Med, July 26, 1993; 153(14): 1705 - 1712. [Abstract] [PDF] |
||||








